期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

鳞状细胞癌抗原监测在宫颈鳞癌治疗中的临床意义 被引量：9

下载PDF
导出
摘要 宫颈癌位居最常见女性恶性肿瘤的第二位；在女性与肿瘤相关的死因中，宫颈癌亦居第二位。其中以子宫颈鳞癌最多见，占90％-95％。中晚期宫颈癌约35％在治疗后会出现复发，复发性或转移性宫颈癌，5年生存率不超过20％。本文通过回顾性分析89例中晚期宫颈鳞癌患者血清鳞状细胞癌抗原（SCC—Ag）的定期监测，联合临床及影像学等辅助检查及时发现复发与转移，以提高中晚期宫颈鳞癌的疗效。
作者 李桂兰 赵桂玲
机构地区 天津市中心妇产科医院妇瘤科
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2010年第11期638-639,共2页 Chinese Journal of Clinical Oncology
关键词 中晚期宫颈鳞癌 鳞状细胞癌抗原 监测 复发
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献7

  • 1连利娟,主编.琳巧稚妇科肿瘤学[M].第4版.北京:人民卫生出版社,2006.389-391.
  • 2赵欣,邵淑丽.鳞状上皮细胞癌抗原与宫颈鳞癌[J].国外医学（妇产科学分册）,2007,34(1):60-62. 被引量：17
  • 3Ohno T,Nakayama Y,Nakamoto S,et al.Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix[J].Cancer,2003,97(12):3114-3120.
  • 4Maneo A,Colombo A,Landoni F,et al.Treatment of stage ID B cervical carcinoma.A comparison between radiotherapy,concurrent chemo-radiotherapy and neoadjuvant chemotherapy[J].Minerva Ginecol,2005,57(2):141-152.
  • 5Torres MA,Jhingran A,Thames HD Jr,et al.Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment[J].Int J Radial Oncol Biol Phys,2008,70(1):118-125.
  • 6Lee MY,Wu HG,Kim K,et al.Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix[J].Gynecol Oncol,2007,104(1):95-99.
  • 7Eifel PJ.Chemoradiotherapy in the treatment of cervical cancer[J].Semin Radiat Oncol,2006,16(3):177-185.

二级参考文献20

  • 1Barnes RC,Coulter J,Worrall DM.Immunoreactivity of recombinant squamous cell carcinoma antigen and leupin/SCCA-2:implications for tumor marker detection[J].Gynecol Oncol,2000,78 (1):62-66.
  • 2Maruo T,Yoshida S,SanotoT,et al.Factors regulating SCC antigen expression in squamous cell carcinoma of the uterine cervix[J].Tumour Biol,1998,19 (6):494-504.
  • 3Iwasaki M,Nishikawa A,Akutagawa N,et al.E1AF/PEA3 reduces the invasiveness of SiHa cervical cancer cells by activating serine proteinase inhibitor squamous cell carcinoma antigen[J].Exp Cell Res,2004,299 (2):525-532.
  • 4Hirakawa H,Nawata S,Sueoka K,et al.Regulation of squamous cell carcinoma antigen production by E-cadherin mediated cell-cell adhesion in squamous cell carcinoma cell line[J].Oncol Rep,2004,11(2):415-419.
  • 5Hashimoto K,Kiyoshima T,Matsuo K,et al.Effect of SCCA1 and SCCA2 on the suppression of TNF-alpha-induced cell death by impeding the release of mitochondrial cytochrome c in an oral squamous cell carcinoma cell line[J].Tumour Biol,2005,26 (4):165-172.
  • 6Sueoka K,Nawata S,Nakagawa T,et al.Tumor-associated serpin,squamous cell carcinoma antigen stimulates matrix metalloproteinase-9production in cervical squamous cell carcinoma cell lines[J].Int J Oncol,2005,27(5):1345-1353.
  • 7Nakashima T,Yasumatsu R,Kuratomi Y,et al.Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma[J].Head Neck,2006,28(1):24-30.
  • 8Murakami A,Nakagawa T,Kaneko M,et al.Suppression of SCC antigen promotes cancer cell invasion and migration through the decrease in E-cadherin expression[J].Int J Oncol,2006,29 (5):1231-1235.
  • 9Molina R,Filella X,Auge JM,et al.CYFRA 21.1 in patients with cervical cancer:comparison with SCC and CEA[J].Anticancer Res,2005,25(3A):1765-1771.
  • 10Buyru N,Tigli H,Duranyildiz D,et al.Molecular detection of squamous cell carcinoma antigen transcripts in peripheral blood of cancer patients[J].Clin Chem Lab Med,2006,44(5):538-541.

共引文献16

同被引文献67

  • 1王孝忠,刘富元,李艳芳,冯艳玲,李玉洁,高克非.复发性宫颈癌48例临床分析[J].肿瘤学杂志,2004,10(5):307-309. 被引量：5
  • 2刘晓玲,车少敏,王文,姜缨,郑伟.血清SCC与宫颈癌生物学行为的相关性及临床意义[J].西安交通大学学报（医学版）,2004,25(6):576-577. 被引量：16
  • 3刘建文,赵瑞峰,李海学.应用MRI评价宫颈癌分期的临床研究[J].现代妇产科进展,2006,15(8):582-585. 被引量：16
  • 4王瑾晖,杨佳欣,沈铿,郎景和,王博诚,朱朝辉.PET在监测宫颈癌复发中的应用[J].现代妇产科进展,2006,15(12):911-913. 被引量：4
  • 5赵欣,邵淑丽.鳞状上皮细胞癌抗原与宫颈鳞癌[J].国外医学（妇产科学分册）,2007,34(1):60-62. 被引量：17
  • 6Gadducci A, Tana R, Fanucchi A, et al. Biochemical prognostic factors and risk relapses in patients with cervical cancer [J]. Gynecol Oncol,2007,107 ( 1 Suppl 1 ) :S23-S26.
  • 7Kim YT, Yoon BS, Kim JW, et al. Pretreatment levels of serum squamous cell carcinoma antigen and urine polyamines in women with squamous cell carcinoma of the cervix [J]. Gynaecol Obstet ,2005,91 ( 1 ) :47-52.
  • 8Forni F, Ferrandina G, Deodato F, et al. Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy : evaluation of cost-effectiveness [ J ]. Int J Radiat Oncol Biol Phys,2007,69 (4): 1145-1149.
  • 9Ferrandina G, Macchia G, Legge F, et al. Squamous cell carcinoma antigen in patients with locally advanced cervi- cal carcinoma undergoing preoperative radiochemothera- py: association with pathological response to treatment and clinical outeome[J]. Ontology,2008,74(1-2) :42-49.
  • 10Hirakawa M, Nagai Y, Inamine M, et al. Predictive factor of distant recur-rence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemora- diotherapy[J]. Gynecol Oncol, 2008, 108(1): 126-129.

引证文献9

二级引证文献30

中国肿瘤临床
2010年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部